scispace - formally typeset
Search or ask a question
Author

Ram K. R. Jetti

Bio: Ram K. R. Jetti is an academic researcher from University of Hyderabad. The author has contributed to research in topics: Crystal structure & Synthon. The author has an hindex of 16, co-authored 23 publications receiving 1319 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: A discussion of the FDA guidance on regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) was held in Manesar near Delhi, India, from February 2-4, 2012 as mentioned in this paper.
Abstract: The December 2011 release of a draft United States Food and Drug Administration (FDA) guidance concerning regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) addressed two matters of topical interest to the crystal engineering and pharmaceutical science communities: (1) a proposed definition of cocrystals; (2) a proposed classification of pharmaceutical cocrystals as dissociable “API-excipient” molecular complexes. The Indo–U.S. Bilateral Meeting sponsored by the Indo–U.S. Science and Technology Forum titled The Evolving Role of Solid State Chemistry in Pharmaceutical Science was held in Manesar near Delhi, India, from February 2–4, 2012. A session of the meeting was devoted to discussion of the FDA guidance draft. The debate generated strong consensus on the need to define cocrystals more broadly and to classify them like salts. It was also concluded that the diversity of API crystal forms makes it difficult to classify solid forms into three categories that...

734 citations

Journal ArticleDOI
TL;DR: In this article, the hexagonal layer structure of host atoms in chloro, bromo, and iodo derivatives of 2,4,6-tris(4-halophenoxy)-1,3,5-triazine, X-POT, is stabilized by a cyclic and cooperative halogen trimer (X···X) synthon.
Abstract: The hexagonal layer structure of host atoms in chloro, bromo, and iodo derivatives of 2,4,6-tris(4-halophenoxy)-1,3,5-triazine, X-POT, is stabilized by a cyclic and cooperative halogen trimer (X···X) synthon. The X···X distance is ∼3.5 A in isostructural channel inclusion adducts of Cl-POT and Br-POT, whereas I···I is ∼3.8 A in cage structures of I-POT with aromatic and hydrophobic guests. X-ray crystal structures of I-POT with mesitylene, collidine, tribromomesitylene, triiodomesitylene, hexachlorobenzene, hexafluorobenzene, 1-methylnaphthalene, CH2Cl2, CH2Br2, and CH2I2 guests in R3 space group are reported. Host molecules are fully ordered in these isostructural clathrates, whereas guest atoms are disordered except for C6Cl6 and C6F6. The guest molecule resides in a penta-decker sandwich surrounded by double layers of iodo trimer and triazine ring. Supramolecular isomerism from channel to cage framework and the persistent crystallization of trigonal X-POT molecules in high-symmetry host networks (spac...

92 citations

Journal ArticleDOI
TL;DR: In this paper, the authors attributed the formation of four isomorphous host-guest complexes in the polar space group P63 to the recurring halogen(guest) and host interaction.

88 citations

Journal ArticleDOI
TL;DR: In this paper, structural studies of low-symmetry structures of 2,4,6-trinitromesitylene and 4,4-diphenyl cyclohexadienone are reported.

83 citations

Journal ArticleDOI
TL;DR: A comparison of hydrogen-bond patterns and lattice energies suggests that the previously obtained form is a kinetic polymorph, while the second polymorph is most likely to represent the more thermodynamically stable form.
Abstract: Too difficult to predict? The second polymorph of the title compound, is presented. A comparison of hydrogen-bond patterns and lattice energies suggests that the previously obtained form (see picture, left) is a kinetic polymorph, while the second polymorph (right) is most likely to represent the more thermodynamically stable form. The new polymorph, however, has two symmetry-independent molecules, which rendered it beyond the limit of previous structural predictions.

77 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: This Perspective provides a brief historical introduction to crystal engineering itself and an assessment of the importance and utility of the supramolecular synthon, which is one of the most important concepts in the practical use and implementation of crystal design.
Abstract: How do molecules aggregate in solution, and how do these aggregates consolidate themselves in crystals? What is the relationship between the structure of a molecule and the structure of the crystal it forms? Why do some molecules adopt more than one crystal structure? Why do some crystal structures contain solvent? How does one design a crystal structure with a specified topology of molecules, or a specified coordination of molecules and/or ions, or with a specified property? What are the relationships between crystal structures and properties for molecular crystals? These are some of the questions that are being addressed today by the crystal engineering community, a group that draws from the larger communities of organic, inorganic, and physical chemists, crystallographers, and solid state scientists. This Perspective provides a brief historical introduction to crystal engineering itself and an assessment of the importance and utility of the supramolecular synthon, which is one of the most important concepts in the practical use and implementation of crystal design. It also provides a look to the future from the viewpoint of the author, and indicates some directions in which this field might be moving.

1,148 citations

Journal ArticleDOI
TL;DR: A discussion of the FDA guidance on regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) was held in Manesar near Delhi, India, from February 2-4, 2012 as mentioned in this paper.
Abstract: The December 2011 release of a draft United States Food and Drug Administration (FDA) guidance concerning regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) addressed two matters of topical interest to the crystal engineering and pharmaceutical science communities: (1) a proposed definition of cocrystals; (2) a proposed classification of pharmaceutical cocrystals as dissociable “API-excipient” molecular complexes. The Indo–U.S. Bilateral Meeting sponsored by the Indo–U.S. Science and Technology Forum titled The Evolving Role of Solid State Chemistry in Pharmaceutical Science was held in Manesar near Delhi, India, from February 2–4, 2012. A session of the meeting was devoted to discussion of the FDA guidance draft. The debate generated strong consensus on the need to define cocrystals more broadly and to classify them like salts. It was also concluded that the diversity of API crystal forms makes it difficult to classify solid forms into three categories that...

734 citations

Journal ArticleDOI
TL;DR: Seven recent case studies that illustrate how pharmaceutical cocrystals can improve physicochemical properties and clinical performance of drug substances, including a recently approved drug product based upon an ICC, are presented.

699 citations